We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$15.6M
Cap. Flow
+$5.46M
Cap. Flow %
2.37%
Top 10 Hldgs %
6.97%
Holding
827
New
263
Increased
114
Reduced
126
Closed
324

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.45M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.42M
3
G icon
Genpact
G
+$1.42M
4
CHRW icon
C.H. Robinson
CHRW
+$1.34M
5
OGE icon
OGE Energy
OGE
+$1.31M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.44M
2
MDLZ icon
Mondelez International
MDLZ
+$1.42M
3
AVT icon
Avnet
AVT
+$1.21M
4
MRVL icon
Marvell Technology
MRVL
+$1.04M
5
XYZ
Block Inc
XYZ
+$987K

Sector Composition

Rank Sector Weight
1 Technology 21.25%
2 Consumer Discretionary 15.35%
3 Healthcare 13.63%
4 Industrials 12.99%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VMI icon
126
Valmont Industries
VMI
$9.53B
$604K 0.26%
1,849
-453
-20% -$139K
SSNC icon
127
SS&C Technologies
SSNC
$18.6B
$603K 0.26%
7,288
+2,925
+67% +$230K
INTU icon
128
Intuit
INTU
$89B
$603K 0.26%
766
+245
+47% +$166K
T icon
129
AT&T
T
$163B
$601K 0.26%
+20,779
New +$573K
UNH icon
130
UnitedHealth
UNH
$370B
$599K 0.26%
+1,919
New +$733K
ZBRA icon
131
Zebra Technologies
ZBRA
$17.8B
$596K 0.26%
1,932
-1,466
-43% -$398K
INSP icon
132
Inspire Medical Systems
INSP
$1.74B
$590K 0.26%
+4,550
New +$660K
ANET icon
133
Arista Networks
ANET
$238B
$588K 0.26%
5,746
-10,034
-64% -$868K
BKNG icon
134
Booking.com
BKNG
$161B
$585K 0.25%
2,525
+350
+16% +$71.7K
JPM icon
135
JPMorgan Chase
JPM
$950B
$577K 0.25%
1,989
+838
+73% +$214K
SFD
136
Smithfield Foods
SFD
$9.99B
$574K 0.25%
+24,381
New +$539K
SARO
137
StandardAero Inc
SARO
$9.7B
$573K 0.25%
+18,120
New +$508K
TGI
138
DELISTED
Triumph Group
TGI
$568K 0.25%
+22,075
New +$563K
ABBV icon
139
AbbVie
ABBV
$435B
$568K 0.25%
+3,061
New +$569K
COLM icon
140
Columbia Sportswear
COLM
$2.94B
$568K 0.25%
9,294
+5,296
+132% +$341K
ROKU icon
141
Roku
ROKU
$22.7B
$562K 0.24%
6,398
+2,404
+60% +$168K
NSC icon
142
Norfolk Southern
NSC
$75.1B
$562K 0.24%
+2,195
New +$518K
Z icon
143
Zillow
Z
$7.56B
$560K 0.24%
+7,996
New +$539K
DOV icon
144
Dover
DOV
$28.4B
$550K 0.24%
+3,002
New +$522K
BSX icon
145
Boston Scientific
BSX
$71.5B
$544K 0.24%
5,066
+1,288
+34% +$130K
MCK icon
146
McKesson
MCK
$101B
$542K 0.24%
+740
New +$522K
NOV icon
147
NOV
NOV
$7B
$542K 0.24%
43,607
-51,570
-54% -$650K
PNR icon
148
Pentair
PNR
$11B
$542K 0.24%
5,278
-1,427
-21% -$133K
KIM icon
149
Kimco Realty
KIM
$16.4B
$541K 0.23%
+25,734
New +$534K
CNC icon
150
Centene
CNC
$32.5B
$540K 0.23%
+9,957
New +$584K
4 5
6
7 8

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Sherbrooke Park Advisers held 827 positions worth $230M, up 7.3% from $215M the previous quarter. Its ten largest holdings account for 7% of the portfolio.

Sherbrooke Park Advisers's Q2 2025 filing shows 263 new, 114 increased, 126 reduced and 324 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M. The largest sale was Merck, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Sherbrooke Park Advisers's largest Q2 2025 buy was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M.
  • Sherbrooke Park Advisers added most to CMS Energy in Q2 2025, an estimated $1.14M increase.
  • Sherbrooke Park Advisers's biggest Q2 2025 reduction was MasTec, cutting an estimated $947K.
  • Sherbrooke Park Advisers fully exited Merck in Q2 2025, selling an estimated $1.44M.
  • Sherbrooke Park Advisers's ten largest holdings make up 7% of its $230M portfolio in Q2 2025.
  • Sherbrooke Park Advisers opened 263 new positions and closed 324 in Q2 2025.
  • Sherbrooke Park Advisers's portfolio value rose 7.3% quarter-over-quarter to $230M.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.